Post by
N0taP00p on Feb 11, 2023 9:04pm
Why execution matters
Another small Toronto company that I bought into a dozen years ago for their amazing robotic surgery technology, hundreds of patents, rolodex of big name surgeons on the advisory board, no debt, etc, finally threw in the towel last week. Will probably find buyers for patents and designs. Never seemed to attract big VC funding (which meant continuous dilution). The design was always getting tweaked, there were continuous delays and frequent funding cycles, many of them total surprises. I did buy into the rah-rah but ended up losing my money.
At least Theralase has a phase 1 approval and FTD. Now, it's all about execution and good communication. Can't use the pandemic as a reason any more. Don't pull surprise raises and delays. Keep the shareholders informed every step of the way in a transparent manner. And above all, my lesson learned is look to for info from posters who are smart but not the blind-faith type. There are a handful of good ones on this board. It's your money, people. Let's hope we get some good news soon. It is overdue.
Comment by
Rumpl3StiltSkin on Feb 12, 2023 9:53am
Poop, We shareholders have very little to worry about, The Data is being collected by the clinicians running the trial. We are on their timeline. I think TLT has the funds in place to get us to that data. Then It is up to the market to catch up... A JV this year, probable. A buyout? Very possible. IMO. :-)
Comment by
N0taP00p on Feb 12, 2023 5:15pm
From your keyboard to God's ears, Rumpl3.